USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: GENOME DATA SYSTEMS, INC.
City: HAMILTON
State: NJ
Zip+4: 99999-
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,143,414.00 6
SBIR Phase II $1,944,745.00 1

Award List:

Modular DC/AC Inverter for Distributed Power

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: DOE
Principal Investigator: Rajan Kumar, President
Award Amount: $99,677.00
Abstract:
65299 Protein microarrays can be used to simultaneously analyze a large subset of the predicted 100,000 human genes, enabling researchers to determine new drug targets, drug effects, toxicity, and leading to a new generation of drugs based on protein function. However, current genome microarrays… More

A HIGH-THROUGHPUT CELL-BASED DRUG DISCOVERY SYSTEM

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Rajan Kumar
Award Amount: $250,000.00
Abstract:
There is a need to expand the use of cell-based assays in high throughput screening systems for diabetes research as well as research into other digestive systems diseases. Genome Data Systems, Inc. (GDS) proposes to design, fabricate and commercialize a high throughput drug discovery system based… More

Microfluidics Laminar Flow Endothelial Cell Assays

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Rajan Kumar
Award Amount: $140,238.00
Abstract:
DESCRIPTION (provided by applicant): Coronary Heart Disease (CHD) and stroke are leading causes of death in the United States. The underlying cause of CHD and stroke is atherosclerosis, which is a chronic inflammatory condition of large arteries. A number of genetic and environmental factors are… More

A High-Throughput Cell-based Drug Discovery System

Award Year / Program / Phase: 2004 / SBIR / Phase II
Agency: HHS
Principal Investigator: Rajan Kumar
Award Amount: $1,944,745.00
Abstract:
DESCRIPTION (provided by applicant): This Phase II SBIR project is focused at the development of a high-throughput screening method and instrument for drug discovery using miniaturized, cell-based assays. For developing new drugs against complex diseases such as diabetes, cancer and neurological… More

LFIA: A Microfluidic Protein Interaction Analysis Method

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Rajan Kumar
Award Amount: $247,604.00
Abstract:
DESCRIPTION (provided by applicant): The primary goals of this SBIR project are 1) to develop a method to detect specific protein interactions by application of laminar flow, and 2) to develop a method to determine rate of protein interactions. Understanding of biomolecular interactions, especially… More

LFMA: Microfluidics-Enabled Microarrays

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Rajan Kumar
Award Amount: $205,908.00
Abstract:
DESCRIPTION (provided by applicant): This application proposes a novel approach to address the highly significant problem of microarray signal variation. Future advances in human health will that use knowledge gained from whole genome molecular analysis. W hole genome expression analysis using DNA… More

IGF::OT::IGF OTHER FUNCTIONS GENOME PHASE I, TOPIC 309, LABEL FREE MULTIVARIATE CANCER DIAGNOSIS

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Rajan Kumar – 609-581-6861
Award Amount: $199,987.00
Abstract:
Breast cancer is a leading cause of malignancies in women, resulting in almost 200,000 new cases every year. In approximately one third of breast cancer patients, malignant cells spread to distant organs and cause metastatic tumors. Tumor progression, metastatic spread and patient prognosis depends… More